Stay updated on Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer displays a newer site revision, changing from v3.7.2 to v3.8.0. The page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T16:31:19.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology changes appears above the 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T18:54:43.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T18:56:44.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous content and navigation. This indicates a permissions or server issue that prevents viewing the trial details and related information.
    Difference
    20%
    Check dated 2026-09-22T22:34:23.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page's revision identifier was bumped from v3.6.6 to v3.7.0, signaling a newer version of the page's documentation rather than a change to study data.
    Difference
    0.1%
    Check dated 2026-09-15T22:15:24.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a small version update.
    Difference
    0.1%
    Check dated 2026-09-01T18:16:20.000Z thumbnail image

Stay in the know with updates to Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab & Nivolumab in Head & Neck Cancer Clinical Trial page.